` 041920 (Mediana Co Ltd) vs KOSPI 200 Comparison - Alpha Spread

M
041920
vs
K
KOSPI 200

Over the past 12 months, Mediana Co Ltd has underperformed KOSPI 200, delivering a return of +61% compared to KOSPI 200's +153% growth.

Stocks Performance
041920 vs KOSPI 200

Loading...
041920
KOSPI 200
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
041920 vs KOSPI 200

Loading...
041920
KOSPI 200
Difference
www.alphaspread.com

Performance By Year
041920 vs KOSPI 200

Loading...
041920
KOSPI 200
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Mediana Co Ltd vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Mediana Co Ltd
Glance View

Market Cap
162.2B KRW
Industry
Health Care

Mediana Co Ltd makes medical equipment used in hospitals and emergency care. Its products include patient monitors, defibrillators, and other devices that help doctors and nurses watch vital signs, respond to cardiac emergencies, and manage patients during treatment. It sells to hospitals, clinics, ambulance services, and distributors that supply healthcare facilities. The company earns money by selling these devices and, in some cases, related accessories, service, and maintenance support. Its customers buy Mediana because the equipment is part of day-to-day clinical work and must be reliable, easy to use, and compatible with hospital routines. That makes the business more tied to installed equipment and healthcare purchasing cycles than to consumer demand. Mediana sits in the middle of the medical device value chain: it turns engineering and regulatory know-how into hardware that frontline caregivers use directly. That role is different from drug makers or hospital operators because the company sells the tools of care rather than the care itself. Its business depends on long product lifecycles, safety standards, and trust from healthcare buyers.

Intrinsic Value
5 796.82
Overvaluation 34%
Intrinsic Value
Price ₩8 720
M
Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett